Cargando…

Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays

Detalles Bibliográficos
Autores principales:	Hovestadt, Volker, Remke, Marc, Kool, Marcel, Pietsch, Torsten, Northcott, Paul A., Fischer, Roger, Cavalli, Florence M. G., Ramaswamy, Vijay, Zapatka, Marc, Reifenberger, Guido, Rutkowski, Stefan, Schick, Matthias, Bewerunge-Hudler, Melanie, Korshunov, Andrey, Lichter, Peter, Taylor, Michael D., Pfister, Stefan M., Jones, David T. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2013
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661908/ https://www.ncbi.nlm.nih.gov/pubmed/23670100 http://dx.doi.org/10.1007/s00401-013-1126-5

Ejemplares similares

Molecular subgroups of medulloblastoma: the current consensus
por: Taylor, Michael D., et al.
Publicado: (2011)

Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
por: Pietsch, Torsten, et al.
Publicado: (2014)

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
por: Kool, Marcel, et al.
Publicado: (2012)

Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
por: Sharma, Tanvi, et al.
Publicado: (2019)

Update on molecular and genetic alterations in adult medulloblastoma
por: Kool, Marcel, et al.
Publicado: (2012)

The WIP1 Oncogene Promotes Progression and Invasion of Aggressive Medulloblastoma Variants
por: Buss, Meghan C., et al.
Publicado: (2014)

Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling
por: Zuckermann, Marc, et al.
Publicado: (2015)

MDB-28. DEEP LEARNING-BASED PERSONALIZED SURVIVAL PREDICTION FOR MEDULLOBLASTOMA
por: Stefan, Sabina, et al.
Publicado: (2023)

Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells
por: Robson, Jonathan P., et al.
Publicado: (2019)

Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
por: Northcott, Paul A., et al.
Publicado: (2011)

ICGC PedBrain - dissecting the genomic complexity underlying medulloblastoma using whole-genome sequencing
por: Jäger, Natalie, et al.
Publicado: (2012)

Coverage Bias and Sensitivity of Variant Calling for Four Whole-genome Sequencing Technologies
por: Rieber, Nora, et al.
Publicado: (2013)

Genome-wide identification of translationally inhibited and degraded miR-155 targets using RNA-interacting protein-IP
por: Meier, Jan, et al.
Publicado: (2013)

Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity
por: Korshunov, Andrey, et al.
Publicado: (2013)

MEDB-41. Identifying a subgroup of patients with early childhood sonic hedgehog-activated medulloblastoma with unfavorable prognosis after treatment with radiation-sparing regimens including intraventricular methotrexate
por: Tonn, Svenja, et al.
Publicado: (2022)

Epigenetic Silencing of DKK3 in Medulloblastoma
por: Valdora, Francesca, et al.
Publicado: (2013)

Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells
por: Kawauchi, D, et al.
Publicado: (2017)

Capture and Amplification by Tailing and Switching (CATS): An ultrasensitive ligation-independent method for generation of DNA libraries for deep sequencing from picogram amounts of DNA and RNA
por: Turchinovich, Andrey, et al.
Publicado: (2014)

MBCL-08. INTEGRATIVE MOLECULAR ANALYSIS OF PATIENT-MATCHED DIAGNOSTIC AND RELAPSED MEDULLOBLASTOMAS
por: Kumar, Rahul, et al.
Publicado: (2020)

Spatial heterogeneity in medulloblastoma
por: Morrissy, A Sorana, et al.
Publicado: (2017)

MBCL-21. GERMLINE ELONGATOR MUTATIONS IN SONIC HEDGEHOG MEDULLOBLASTOMA
por: Robinson, Giles W, et al.
Publicado: (2020)

Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
por: Lee, Catherine, et al.
Publicado: (2019)

Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group
por: Gottardo, Nicholas G., et al.
Publicado: (2013)

Group-specific cellular metabolism in Medulloblastoma
por: Funke, Viktoria L. E., et al.
Publicado: (2023)

MBRS-48. IDENTIFICATION OF NOVEL THERAPEUTIC APPROACHES FOR MYC-DRIVEN MEDULLOBLASTOMA
por: Taban, Kübra, et al.
Publicado: (2020)

Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma
por: Park, Ae Kyung, et al.
Publicado: (2019)

Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress
por: Oh, Sekyung, et al.
Publicado: (2016)

Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse model
por: Simovic, Milena, et al.
Publicado: (2021)

Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses
por: Okonechnikov, Konstantin, et al.
Publicado: (2023)

Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma
por: Rickert, Daniel, et al.
Publicado: (2021)

MDB-29. MEDULLOBLASTOMA SUBGROUP-SPECIFIC CHROMATIN STATES REVEAL NOVEL THERAPEUTIC VULNERABILITIES
por: Tao, Ran, et al.
Publicado: (2023)

IMMU-19. HDAC INHIBITORS SENSITIZE MYC-AMPLIFIED MEDULLOBLASTOMA TO IMMUNOTHERAPY BY ACTIVATING THE NF-kB PATHWAYS
por: Marquardt, Viktoria, et al.
Publicado: (2020)

Germline GPR161 Mutations Predispose to Pediatric Medulloblastoma
por: Begemann, Matthias, et al.
Publicado: (2020)

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
por: Remke, Marc, et al.
Publicado: (2013)

Mitochondrial DNA mutations in Medulloblastoma
por: Funke, Viktoria L. E., et al.
Publicado: (2023)

Overcoming multiple drug resistance mechanisms in medulloblastoma
por: Othman, Ramadhan T, et al.
Publicado: (2014)

EMBR-01. CLASS I HDAC INHIBITORS AND PLK1 INHIBITORS SYNERGIZE IN MYC-AMPLIFIED MEDULLOBLASTOMA
por: Valinciute, Gintvile, et al.
Publicado: (2021)

Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours
por: von Bueren, A O, et al.
Publicado: (2012)

MBRS-04. MEDULLOBLASTOMA DETECTION BY BLOOD TEST
por: Yalon, Michal, et al.
Publicado: (2020)

The whole-genome landscape of medulloblastoma subtypes
por: Northcott, Paul A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_85j6lmfbl4d4une9rscb52e46g